Idiopathic pulmonary arterial hypertension

Area of Science:

• Cardiology
• Pulmonology
• Genetics

Background:

• Idiopathic pulmonary arterial hypertension (IPAH) is a rare disease with varying clinical presentations.
• PAH can be associated with diverse conditions, necessitating exclusion of other diagnoses for an IPAH diagnosis.
• The
• Multiple hit
• concept suggests genetic abnormalities and environmental factors contribute to IPAH development.

Purpose of the Study:

• To review the current understanding of IPAH, including its diagnosis, contributing factors, and therapeutic landscape.
• To highlight the advancements in treatment options and their impact on patient outcomes.
• To emphasize the need for novel therapeutic strategies due to persistent high mortality rates.

Main Methods:

• Literature review of idiopathic pulmonary arterial hypertension (IPAH) and pulmonary arterial hypertension (PAH).
• Analysis of diagnostic criteria and etiological factors for IPAH.
• Evaluation of current and emerging therapeutic options for PAH.

Main Results:

• IPAH diagnosis requires ruling out secondary causes of PAH.
• Genetic factors and environmental exposures are implicated in IPAH pathogenesis.
• Despite available treatments, 5-year mortality remains around 40%.

Conclusions:

• Combination therapy, using agents with different mechanisms, is recommended for IPAH.
• Ongoing research into new therapeutic agents and strategies is crucial for improving survival.
• Further investigation into the "multiple hit" concept may reveal new therapeutic targets.